News
Health and Me on MSN8h
Not Wegovy or Mounjaro Or Ozempic: This New Monthly Weight Loss Jab Helped People Drop 20% Body FatA new monthly weight loss drug, MariTide, helped people shed up to 20% of body weight in a Phase 2 trial—comparable to Wegovy ...
In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...
The Beat AML Master Trial found high remission rates and promising safety with triplet therapy in patients with acute myeloid leukemia (AML), according to Ashley Yocum, PhD.
Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after ...
17h
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...
Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...
Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...
1d
Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...
Results from the Phase III REDEFINE 1 trial show that CagriSema led to a 22.7% mean weight reduction at 68 weeks in adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback